Thermo Fisher Scientific Stock-Based Compensation 2010-2025 | TMO
Thermo Fisher Scientific annual/quarterly stock-based compensation history and growth rate from 2010 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
- Thermo Fisher Scientific stock-based compensation for the quarter ending March 31, 2025 was $301M, a 8.27% increase year-over-year.
- Thermo Fisher Scientific stock-based compensation for the twelve months ending March 31, 2025 was $747M, a 3.61% increase year-over-year.
- Thermo Fisher Scientific annual stock-based compensation for 2024 was $0.301B, a 8.27% increase from 2023.
- Thermo Fisher Scientific annual stock-based compensation for 2023 was $0.278B, a 9.45% decline from 2022.
- Thermo Fisher Scientific annual stock-based compensation for 2022 was $0.307B, a 33.48% increase from 2021.
| Thermo Fisher Scientific Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2024 | $301 |
| 2023 | $278 |
| 2022 | $307 |
| 2021 | $230 |
| 2020 | $196 |
| 2019 | $181 |
| 2018 | $181 |
| 2017 | $159 |
| 2016 | $133 |
| 2015 | $125 |
| 2014 | $117 |
| 2013 | $91 |
| 2012 | $78 |
| 2011 | $80 |
| 2010 | $82 |
| 2009 | $67 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $159.887B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||